A new blood test could speed up diagnosis and treatment for people dealing with early memory or thinking changes. The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to ...

A simple blood test might detect women at risk for cognitive decline and dementia 25 years before any symptoms appear. The blood test looks for high levels of a protein called p-tau217, indicating ...

Whoop Inc., the maker of popular screenless fitness bands, is expanding its features for women with a new blood test that offers a more comprehensive view of their health. The update builds on Whoop’s ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." According to the NIH, Alzheimer's disease accounts for up to two-thirds of dementia cases in people 65 ...

An integrated suite of bioassays provides a coherent workflow to track antibody Fc effector activity across every stage of mAb drug development Potency assays that fail during tech transfer or ...

In a nutshell: As the global population ages, Alzheimer's disease has become one of the most common forms of dementia affecting older adults. Traditional diagnostic methods are often expensive and ...

A Silicon Valley-based company’s innovative blood test, designed to identify cancer early, hit the market five years ago and even cameoed in a recent Super Bowl ad. But new results from a large ...

A simple blood test could predict not only a person’s risk of developing Alzheimer’s disease, but also the year symptoms will begin. Researchers at the Washington University School of Medicine in St.

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. Quest Flow ...

A new blood test may reveal Crohn’s disease years before symptoms begin. The test detects an unusual immune response to gut bacteria in people who later develop the condition. By studying healthy ...